Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Context: Colorectal cancer (CRC) is a leading cause of cancer deaths. Recently, much attention has been given to the microbiome and probiotics as preventive and therapeutic approaches to CRC and the mechanisms involved. Objectives: To interpret the findings of randomized controlled trials (RCTs) of probiotics relative to patients with CRC and to outline challenges of and future directions for using probiotics in the management and prevention of CRC. Data sources: Web of Science, PubMed, ProQuest, Wile,y and Scopus databases were searched systematically from January 17–20, 2020, in accordance with PRISMA guidelines. Study selection: Primacy RCTs that reported the effects of administration to patients with CRC of a probiotic vs a placebo were eligible to be included. Data Extraction: The studies were screened and selected independently by 2 authors on the basis of prespecified inclusion and exclusion criteria. The data extraction and risk-of-bias assessment were also performed independently by 2 authors. Results: A total of 23 RCTs were eligible for inclusion. Probiotics supplementation in patients with CRC improved their quality of life, enhanced gut microbiota diversity, reduced postoperative infection complications, and inhibited pro-inflammatory cytokine production. The use of certain probiotics in patients with CRC also reduced the side effects of chemotherapy, improved the outcomes of surgery, shortened hospital stays, and decreased the risk of death. Bifidobacteria and Lactobacillus were the common probiotics used across all studies. Conclusion: Probiotics have beneficial effects in patients with CRC regardless of the stage of cancer. There is an opportunity for probiotics to be used in mainstream health care as a therapy in the fight against CRC, especially in early stages; however, larger clinical trialsof selected or a cocktail of probiotics are needed to confirm the efficacy, dosage, and interactions with chemotherapeutics agents. Systematic Review Registration: PROSPERO registration no. CRD42020166865.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Probiotic supplements might not be universally-effective and safe: A review
Kothari, D., Patel, S., & Kim, S.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.104 · Cited by 445
Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention
Song, M., & Chan, A. T. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.012 · Cited by 355
Importance of probiotics in the prevention and treatment of colorectal cancer
Eslami, M., Yousefi, B., Kokhaei, P., Hemati, M., Nejad, Z. R., Arabkari, V., & Namdar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28473 · Cited by 285
Gianotti, L. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i2.167 · Cited by 209
Whelan, K., & Myers, C. E. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28759 · Cited by 161
Huys, G., Botteldoorn, N., Delvigne, F., De Vuyst, L., Heyndrickx, M., Pot, B., Dubois, J., & Daube, G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300065 · Cited by 132
Roller, M., Clune, Y., Collins, K., Rechkemmer, G., & Watzl, B. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507450292 · Cited by 125
Cited by
Dikeocha, I. J., Al-Kabsi, A. M., Chiu, H.-T., & Alshawsh, M. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051128 · Cited by 116
Self-citationDong, Y., Zhang, K., Wei, J., Ding, Y., Wang, X., Hou, H., Wu, J., Liu, T., Wang, B., & Cao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158200 · Cited by 107
Wang, X., Huang, Y., Yang, Z., Yang, Y., Wei, F., Yan, M., Li, F., & Wang, C. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03604-9 · Cited by 18
“Additionally, the toxic effects of chemotherapeutic drugs can dampen the associated inflammatory cells and affect the body’s immunity [14, 15].”
ESKAPEE Pathogen Biofilm Control on Surfaces with Probiotic Lactobacillaceae and Bacillus species
Neidhöfer, C., Rathore, K., Parčina, M., & Sieber, M. A. (2023) · Antibiotics · doi:10.3390/antibiotics12050871 · Cited by 15
Metadata
- Authors
- Dikeocha, I. J., Al-Kabsi, A. M., Eid, E. E. M., Hussin, S., & Alshawsh, M. A.
- Venue
- Nutrition Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-24
- Volume
- 80
- Issue
- 1
- Pages
- 22-49
- ISSN
- 0029-6643 (ISSN-L)
- 1753-4887
- OpenAlex
- W3164188038
- Cited by
- 60
- References
- 15
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials. https://app.cochat.ai/papers/10.1093/nutrit/nuab006
- The paper
- Dikeocha, I. J., Al-Kabsi, A. M., Eid, E. E. M., Hussin, S., & Alshawsh, M. A. (2021). Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuab006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.